Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial.
Inhibition of acylglycerol acyltransferase 1 with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial